Article
Author(s):
A case study details the care of a patient who had already lost vision in one eye from a similar issue.
Zeiss Medical Technology gains NMPA approval for ILM-Blue in China
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
ZEISS VISULAS Combi availability expands to Canada
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
US News & World Report releases list of best ophthalmology ambulatory surgical centers in the US
FDA approves expanded label for fluocinolone acetonide intravitreal implant